Amalgamated Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $91K | Hold |
3,159
| – | – | ﹤0.01% | 1713 |
|
2025
Q1 | $106K | Buy |
3,159
+467
| +17% | +$15.7K | ﹤0.01% | 1668 |
|
2024
Q4 | $138K | Hold |
2,692
| – | – | ﹤0.01% | 1651 |
|
2024
Q3 | $138K | Hold |
2,692
| – | – | ﹤0.01% | 1648 |
|
2024
Q2 | $121K | Buy |
2,692
+464
| +21% | +$20.9K | ﹤0.01% | 1679 |
|
2024
Q1 | $104K | Sell |
2,228
-4,271
| -66% | -$199K | ﹤0.01% | 1713 |
|
2023
Q4 | $231K | Buy |
6,499
+201
| +3% | +$7.14K | ﹤0.01% | 1751 |
|
2023
Q3 | $187K | Buy |
6,298
+592
| +10% | +$17.6K | ﹤0.01% | 1807 |
|
2023
Q2 | $103K | Sell |
5,706
-3
| -0.1% | -$54 | ﹤0.01% | 2051 |
|
2023
Q1 | $92K | Sell |
5,709
-1,259
| -18% | -$20.3K | ﹤0.01% | 2086 |
|
2022
Q4 | $128K | Hold |
6,968
| – | – | ﹤0.01% | 2034 |
|
2022
Q3 | $137K | Buy |
6,968
+74
| +1% | +$1.46K | ﹤0.01% | 1999 |
|
2022
Q2 | $129K | Sell |
6,894
-334
| -5% | -$6.25K | ﹤0.01% | 2067 |
|
2022
Q1 | $159K | Sell |
7,228
-558
| -7% | -$12.3K | ﹤0.01% | 2027 |
|
2021
Q4 | $221K | Buy |
+7,786
| New | +$221K | ﹤0.01% | 1941 |
|